Impact of Adalimumab on Patient-reported Outcomes in Ulcerative Colitis

Clinical trial NCT02506179 · COMPLETED

Trial details

NCT number: NCT02506179
Sponsor: AbbVie
Status: COMPLETED
Study type: OBSERVATIONAL

Ulcerative Colitis

Start date: 2015-08-18
Primary completion: 2020-02-10
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.